IMARC Group has recently released a new research study titled “United States Infection Control Market Size, Share, Trends and Forecast by Type, End User, and Region, 2025-2033” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The United States infection control market size was valued at USD 12.75 Billion in 2024 and is projected to reach USD 22.25 Billion by 2033, growing at a CAGR of 6.29% during the forecast period 2025-2033. The market expansion is driven by increasing hospital-acquired infections (HAIs), rigorous regulatory standards, and advancements in sterilization technologies. Growing healthcare investments and the adoption of single-use medical products and automated disinfection systems are also key contributors to market growth across hospitals, laboratories, and pharmaceutical sectors.

Study Assumption Years

●     Base Year: 2024

●     Historical Year/Period: 2019-2024

●     Forecast Year/Period: 2025-2033

United States Infection Control Market Key Takeaways

●     Current Market Size in 2024: USD 12.75 Billion

●     CAGR (2025-2033): 6.29%

●     Forecast Period: 2025-2033

●     The market growth is fueled by rising incidences of hospital-acquired infections (HAIs), stringent regulatory policies imposed by CDC, FDA, and other entities.

●     Advancements in sterilization technologies like vaporized hydrogen peroxide (VHP), UV-C light systems, and antimicrobial coatings are driving demand.

●     Increasing outsourcing of infection control services by healthcare facilities results in cost savings and operational efficiency.

●     Rising demand for personal protective equipment (PPE) post-pandemic continues, supported by investments to replenish strategic national stockpiles.

●     The market benefits from government initiatives upgrading sanitation in public healthcare and growing healthcare expenditure.

Sample Request Link: https://www.imarcgroup.com/united-states-infection-control-market/requestsample

To get more information on this market,  Request Sample

United States Infection Control Market Growth Factors

The infection control market in the United States is expanding steadily, driven by the increasing incidence of hospital-acquired infections (HAIs), which has prompted healthcare providers to adopt more advanced prevention and containment technologies. Strict regulatory requirements enforced by agencies such as the CDC and FDA mandate rigorous sterilization, disinfection, and safety protocols, further accelerating the uptake of innovative infection control solutions. In October 2023, the CDC issued draft guidelines recommending the use of NIOSH-approved respirators, eye protection, and comprehensive risk assessments to minimize pathogen transmission in healthcare environments. Additionally, aging demographics and the rising prevalence of chronic diseases have increased hospitalization rates, reinforcing the need for robust infection prevention measures.

Technological advancements represent a key catalyst for market growth. Modern sterilization techniques, including vaporized hydrogen peroxide (VHP), ultraviolet (UV) disinfection, ethylene oxide (EtO), and antimicrobial surface coatings, have significantly improved hygiene standards across healthcare facilities. Ethylene oxide alone is used to sterilize nearly half of the approximately 20 billion sterile medical devices sold annually in the United States. Furthermore, the FDA’s designation of vaporized hydrogen peroxide as a standardized sterilization method in January 2024 has encouraged broader adoption, while automation in sterilization equipment has enhanced operational efficiency and contamination control within hospitals.

Rising demand for personal protective equipment (PPE) continues to support market expansion. Although the acute phase of the pandemic has passed, strict PPE usage remains standard practice across healthcare, laboratory, and pharmaceutical settings. In October 2024, six U.S.-based manufacturers invested approximately USD 350 million to produce medical gowns for the Strategic National Stockpile, addressing vulnerabilities exposed during earlier supply shortages. At the same time, innovation in antimicrobial textiles, reusable high-filtration masks, and advanced protective materials is complementing sustained demand for gloves, masks, and gowns. Additionally, the growing outsourcing of infection control services by hospitals and clinics is improving operational efficiency and cost management, further strengthening the market outlook.

United States Infection Control Market Segmentation

Analysis by Type:

●     Equipment

●     Disinfectors

●     Washers

●     Flushers

●     Ultrasonic Cleaners

●     Sterilization Equipment

●     Heat Sterilization

●     Low Temperature Sterilization

●     Radiation Sterilization

●     Filtration-Based Sterilization

●     Others

●     Services

●     Contract Sterilization

●     ETO Sterilization

●     Gamma Sterilization

●     E-Beam Sterilization

●     Steam Sterilization

●     Infectious Waste Disposal

●     Consumables

●     Disinfectants

●     Sterilization Consumables

●     Personal Protective Equipment

●     Others

The equipment segment includes devices like sterilizers and disinfection systems critical for maintaining sterile environments in hospitals and laboratories. Autoclaves, vaporized hydrogen peroxide (VHP) sterilizers, and ultrasonic cleaners eliminate pathogens on medical instruments. Automated and AI-driven disinfection technologies are increasingly demanded for infection control and regulatory compliance.

Infection control services cover decontamination, sterilization validation, equipment maintenance, and waste management. Outsourced sterilization services for single-use devices and biopharmaceuticals drive market growth, complemented by environmental disinfection via hydrogen peroxide vapor and UV sterilization.

Consumables include disinfectants, sterilization wraps, gloves, masks, gowns, and single-use medical supplies essential to prevent cross-contamination. Demand for high-level disinfectants, alcohol-based sanitizers, antimicrobial coatings, and PPE kits is rising as hospitals and clinics maintain infection prevention protocols.

Analysis by End User:

●     Hospitals and Clinics

●     Medical Device Companies

●     Clinical Laboratories

●     Pharmaceutical Companies

●     Others

Hospitals and clinics represent the largest end-users requiring sterilization protocols, disinfection, and PPE to control hospital-acquired infections. Medical device companies emphasize sterilization to ensure product safety, using EtO, gamma radiation, and vaporized hydrogen peroxide. Clinical laboratories implement biosafety cabinets and high-level disinfectants to manage infectious samples and testing. Pharmaceutical companies focus on contamination control in drug manufacturing with cleanroom sterilization and air filtration.

Regional Insights

The Northeast region dominates the United States infection control market due to a dense concentration of hospitals, research institutions, and pharmaceutical companies. Key states like New York, Massachusetts, and Pennsylvania enforce stringent infection prevention regulations, spurring demand for advanced sterilization and antimicrobial coatings. The aging population, hefty healthcare expenditures, urban density, and frequent travel increase infection risks and investments in hospital-acquired infection control programs.

Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=20447&flag=C

Recent Developments & News

●     In January 2024, ICP Medical, a division of TEAM Technologies, launched a new website integrating infection control solutions, e-commerce, and instructional resources.

●     In July 2024, BioVigil enhanced its user badges with improved sensing technology and battery life to strengthen hand hygiene monitoring, reduce HAIs, and support contact tracing in healthcare.

●     In November 2024, Ondine Biomedical announced preparations for a U.S. Phase 3 trial with HCA Healthcare to assess Steriwave® nasal photodisinfection aimed at reducing hospital-associated infections and antimicrobial resistance across 14 hospitals.

Key Players

●     APIC

●     ICP Medical (division of TEAM Technologies)

●     BioVigil

●     Ondine Biomedical

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302